Gene · 112398
Papers1,689
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,689
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased susceptibility of human limbal aniridia fibroblasts to oxidative stress. | Exp Eye Res | 2024 | 39303843 | PubTator, text mining | PubMed |
| Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response. | Cell Rep | 2024 | 39255062 | PubTator, text mining | PubMed |
| Systematic discovery of DNA-binding tandem repeat proteins. | Nucleic Acids Res | 2024 | 39189466 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Protein Footprinting Defines the Binding Pocket of Crotonylated H3K14 in the PHD1 Domain of BAF45D within the BAF Chromatin Remodeling Complex. | ACS Bio Med Chem Au | 2024 | 39184054 | PubTator, text mining | PubMed |
| Mechanism for controlled assembly of transcriptional condensates by Aire. | Nat Immunol | 2024 | 39169234 | PubTator, text mining | PubMed |
| Transcriptome analysis of human dental pulp cells cultured on a novel cell-adhesive fragment by RNA sequencing. | Gene | 2024 | 38901533 | PubTator, text mining | PubMed |
| DPF2-related Coffin-Siris syndrome type 7 in two generations. | Eur J Med Genet | 2024 | 38697389 | PubTator, text mining | PubMed |
| The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia. | Nat Cancer | 2024 | 38637657 | PubTator, text mining | PubMed |
| Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-κB signaling pathway leads to the formation of a loop between HIF-1α and MUC1-C promoting chemoresistance in bladder cancer. | Mol Carcinog | 2024 | 38634741 | PubTator, text mining | PubMed |
| Targeted RNAseq Revealed the Gene Expression Signature of Ferroptosis-Related Processes Associated with Disease Severity in Patients with Multiple Sclerosis. | Int J Mol Sci | 2024 | 38474262 | PubTator, text mining | PubMed |
| Identifying ligands for the PHD1 finger of KDM5A through high-throughput screening. | RSC Chem Biol | 2024 | 38456036 | PubTator, text mining | PubMed |
| Guiding the HBO1 complex function through the JADE subunit. | Nat Struct Mol Biol | 2024 | 38448574 | PubTator, text mining | PubMed |
| VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation. | EMBO J | 2024 | 38360997 | PubTator, text mining | PubMed |
| Yin Yang 1 facilitates the activation, inflammation, and extracellular matrix deposition of hepatic stellate cells in hepatic fibrosis. | Pathol Int | 2024 | 38353379 | PubTator, text mining | PubMed |
| Roles of exosomes in immunotherapy for solid cancers. | Cell Death Dis | 2024 | 38302430 | PubTator, text mining | PubMed |
| Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition. | J Transl Med | 2024 | 38268032 | PubTator, text mining | PubMed |
Comparison of outcomes on hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) in anaemia associated with chronic kidney disease: network meta-analyses in dialysis and non-dialysis dependent populations. | Clin Kidney J | 2024 | 38250252 | PubTator, text mining | PubMed |
| Hypoxia-Inducible Factor and Oxidative Stress in Tendon Degeneration: A Molecular Perspective. | Antioxidants (Basel) | 2024 | 38247510 | PubTator, text mining | PubMed |
| USP11 promotes glycolysis by regulating HIF-1α stability in hepatocellular carcinoma. | J Cell Mol Med | 2024 | 38229475 | PubTator, text mining | PubMed |
| Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine. | Sci Rep | 2024 | 38167627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/112398/papers?page=4